Net Revenue: $12.4 million, a 39% increase year over year.Adjusted EBITDA: $700,000, marking a $1.1 million improvement compared to the same period in 2024.Gro
TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-b
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (”Rubicon Organics” or the ”Company”),
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) to release Q1 2025 earnings on May 27, 2025, after market close. Earnings call scheduled for May 28, 2025,
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) to participate in the Planet MicroCap Showcase and ICBC Berlin B2B events in April 2025. CEO Margaret Brodi
Net Revenue: Record high of $14.2 million for Q4 and $48.7 million for the full year 2024.Revenue Growth: 21% increase for Q4 and 42% increase for the full yea
Apr 02, 2025 / 02:00PM GMTOperator Good morning, everyone. Welcome to the conference call for Rubicon Organics Q4 financial results for the 3 and 12 months ende